期刊文献+

ZEB2与E-cadherin在前列腺癌发生、发展中的表达意义

Significance of ZEB2 and E-cadherin in the occurrence and development of prostate cancer
下载PDF
导出
摘要 目的研究E盒结合锌指蛋白2(ZEB2)与E-钙黏蛋白(E-cadherin)在前列腺癌发生、发展中的表达意义。方法选取河北省唐山市协和医院2016年1月—2019年3月88例前列腺标本,其中60例前列腺癌组织为观察组,28例良性前列腺增生组织为对照组,采用免疫组化SP法检测两组患者ZEB2、E-cadherin蛋白表达。分析ZEB2和E-cadherin蛋白表达与前列腺癌临床病理参数的关系。结果两组ZEB2、E-cadherin蛋白阳性表达率比较,差异有高度统计学意义(P<0.01)。ZEB2、E-cadherin蛋白的表达与前列腺癌患者TNM分期和骨转移密切相关(P<0.05或P<0.01),而与年龄和Gleason分级无关(P>0.05)。Spearman等级相关分析显示,前列腺癌组织中ZEB2与E-cadherin蛋白的表达呈负相关(r=-0.377,P<0.01)。结论ZEB2蛋白的高表达与E-cadherin蛋白的表达降低在前列腺癌的发生、发展中可能发挥重要作用。 Objective To study the expression significance of zinc-finger E-box binding protein 2(ZEB2)and E-cadherin in the occurrence and development of prostate cancer.Methods A total of 88 prostate specimens from Tangshan Union Medical College Hospital from January 2016 to March 2019 were selected.Among them,a total of 60 prostate cancer tissues were in the observation group and a total of 28 benign prostate hyperplasia tissues were in the control group.The immunohistochemical SP method was used to detect ZEB2 and E-cadherin protein in the two groups.The relationship between ZEB2 and E-cadherin protein expression and clinicopathological parameters of prostate cancer were analyzed.Results The positive expression rate of ZEB2 and E-cadherin between the two groups were compared,and the differences were highly statistically significant(P<0.01).The expression of ZEB2 and E-cadherin protein were closely related to the TNM staging and bone metastasis of prostate cancer patients(P<0.05 or P<0.01),but had nothing to do with age and Gleason grade(P>0.05).Spearman rank correlation analysis showed that ZEB2 and E-cadherin protein expression in prostate cancer tissue were negatively correlated(r=-0.377,P<0.01).Conclusion The high expression of ZEB2 protein and the reduced expression of E-cadherin protein may play an important role in the occurrence and development of prostate cancer.
作者 王迎宾 李丹丹 付玉环 鱼学农 WANG Yingbin;LI Dandan;FU Yuhuan;YU Xuenong(Department of Urology,Tangshan Union Medical College Hospital,Hebei Province,Tangshan063000,China;Department of Pathology,Tangshan Union Medical College Hospital,Hebei Province,Tangshan063000,China;Department of Pathology,Tangshan Vocational and Technical College,Hebei Province,Tangshan063000,China)
出处 《中国医药导报》 CAS 2020年第29期102-105,共4页 China Medical Herald
基金 河北省唐山市科技局项目(15130237a)。
关键词 前列腺癌 E盒结合锌指蛋白2 E-钙黏蛋白 良性前列腺增生 Prostate cancer Zinc-finger E-box binding protein 2 E-cadherin Benign prostate hyperplasia
  • 相关文献

参考文献12

二级参考文献66

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1363
  • 2Nanda A, Chen M, Renshaw A, et al. Gleason pattern 5prostate cancer: Further stratification of patients withhigh-risk disease and implications for future random ized trials. Int J Radiat Oncol Biol Phys 2009; 74:1419-23.
  • 3McGuire BB, Helfand BT, Loeb S, et al. Outcomes inpatients with Gleason score 8-10 prostate cancer: Relationto preoperative PSA level. BJU Int 2012; 109:1764-9.
  • 4Krauss DJ, Hayek S, Amin M, et al. Prognostic significanceof neuroendocrine differentiation in patients withGleason score 8-10 prostate cancer treated with primaryradiotherapy. Int J Radiat Oncol Biol Phys 2011;81:119-25.
  • 5Serni S, Masieri L, Minervini A, et al. Cancer progressionafter anterograde radical prostatectomy for pathologicGleason score 8 to 10 and influence of concomitantvariables. Urology 2006; 67:373-8.
  • 6Stock R, Cesaretti J, Hall S, et al. Outcomes for patientswith high-grade prostate cancer treated with a combinationof brachytherapy, external beam radiotherapyand hormonal therapy. BJU Int 2009; 104:1631-6.
  • 7Ellis CL, Partin AW, Han M, et al. Adenocarcinoma of theprostate with Gleason score 9-10 on core biopsy:Correlation with findings at radical prostatectomy andprognosis. J Urol 2013; 190:2068-73.
  • 8Humphrey PA. Gleason pattern 5 adenocarcinoma inprostate needle biopsy. J Urol 2012; 188:1341-2.
  • 9Consensus Consensus statement: Guidelines for PSAfollowing radiation therapy. American Society forTherapeutic Radiology and Oncology Consensus Panel.Int J Radiat Oncol Biol Phys 1997; 37:1035-41.
  • 10Sabolch A, Feng F, Daignault-Newton S, et al. Gleasonpattern 5 is the greatest risk factor for clinical failureand death from prostate cancer after dose-escalatedradiation therapy and hormonal ablation. Int J RadiatOncol Biol Phys 2011; 81:351-60.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部